Syneos Health is one of the major global CROs, combining clinical development services with commercial, consulting, and medical affairs capabilities. Its model is built around supporting sponsors from development through commercialization, making it relevant across the full product lifecycle.

Swedish Orphan Biovitrum, commonly known as Sobi, is one of Europe’s most important rare disease and orphan drug companies. The company focuses on rare hematology, immunology, and specialty care, with a portfolio designed for specialist-managed diseases.

Supernus Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Specialty Pharma Companies 1 ranking category Overview

Stoke Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Soleno Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Sobi is a Swedish specialty pharmaceutical company focused on rare diseases, hematology, immunology, and specialty care. The company’s portfolio and commercial model are closely aligned with orphan and specialist-managed diseases.

SK pharmteco is a global CDMO backed by SK Group, providing services across small molecule APIs, advanced intermediates, cell and gene therapy, viral vector manufacturing, and related pharmaceutical production. Its platform combines U.S., European, and Asian manufacturing assets.

SK bioscience is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Sinovac Biotech is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Simbec-Orion is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Siegfried is a Swiss CDMO with strong capabilities in drug substance and drug product manufacturing, including active pharmaceutical ingredients, intermediates, oral solid dosage, sterile filling, and related development services. The company has built a strong reputation in pharmaceutical outsourcing across both chemical and finished-dose manufacturing.

Servier is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Serum Institute of India is one of the most important vaccine manufacturers in the world by volume. Its institutional role is especially important in low- and middle-income countries, where large-scale affordable vaccine supply is essential to immunization programs.

Sarepta Therapeutics is one of the most important rare disease and neuromuscular gene therapy developers. The company is strongly associated with Duchenne muscular dystrophy, where it has developed RNA-based exon-skipping therapies and gene therapy approaches for severe neuromuscular disease.

Sanofi is one of the world’s leading vaccine companies and a major participant in immunology. Its vaccine business, historically associated with Sanofi Pasteur, spans influenza, pediatric vaccines, meningococcal disease, travel vaccines, and respiratory disease prevention.

Sana Biotechnology is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Samsung Biologics is one of the most important biologics CDMO providers globally and a defining player in large-scale mammalian cell culture manufacturing. The company has built a highly standardized, large-capacity manufacturing platform in South Korea, serving major pharmaceutical and biotechnology clients across biologics development and commercial supply.

Rocket Pharmaceuticals is a specialist gene therapy company focused on rare diseases, including hematologic, immunologic, and cardiovascular genetic disorders. The company uses both lentiviral and AAV-based approaches, giving it modality diversity within genetic medicine.

Rhythm Pharmaceuticals is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Revolution Medicines is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview